Tioga Pharmaceuticals Inc

SAN DIEGO, CA · Founded 2005 · CIK 0001331886 · Biotech · Private

Non-hormonal small-molecule therapeutics for women's health conditions

tiogapharma.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$24M
4 Form D · Apr 2012
174 months since last filing
Contracts
—
No federal contracts on record
Patents
5
1 granted · 4 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$2,000,000
Private capital raisedForm D · SEC$3,000,000
Private capital raisedForm D · SEC$9,263,273
Private capital raisedForm D · SEC$10,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1166Arcus Biosciences——
1167LARIX BIOSCIENCE LLC——
1168Neumentum, Inc.—$27M
1169Tioga Pharmaceuticals Inc—$24M
1170KODIAK BP, LLC—$13M
1171Nova Mentis Life Science Corp.—$188K
1172SCYNEXIS, INC.—$5.5M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 9 related persons
  • Jason BrownDirector
  • Stuart CollinsonDirector · Executive Officer
  • Arno HartmannDirector
  • Gareth HicksExecutive Officer
  • Allen MangelExecutive Officer
  • Martin MeunchbachDirector
  • Martin MuenchbachDirector
  • James NiedelDirector
  • David UrsoDirector · Executive Officer

Patents

USPTO · 1 granted of 5
  • Solid Pharmaceutical Formulations Of Asimadolinegranted
  • Splid Pharmaceutical Formulations Of Asimadolineapplication
  • Solid Pharmaceutical Formulations Of Asimadolineapplication
  • Solid Pharmaceutical Formulations Of Asimadolineapplication
  • Kappa-opiate Agonists For The Treatment Of Diarrhea-predominant And Alternating Irritable Bowel Syndromeapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.